BACKGROUND: The combination of gene therapy and plastic surgery may have the potential to improve the specificity that is needed to achieve clinically applicable treatment regimens. Our goal was to develop a method for gene modification that would yield sustainable production of gene products but would be less time consuming than existing protocols. METHODS: An adenoassociated virus was used to deliver gene products to pectoralis muscle flaps. Gene modification was accomplished via either direct injection or novel fat grafting techniques. RESULTS: The production of gene product was observable by both in vivo imaging and immunohistochemical staining. Gene products were not detected in tissues that were not in contact with the fat grafts that were incubated with the viral vector, indicating that the transduction stayed local to the flap. CONCLUSIONS: Using novel recombinant adenoassociated virus vectors, we have developed a method for gene delivery that is highly efficient and applicable to muscle flaps.
BACKGROUND: The combination of gene therapy and plastic surgery may have the potential to improve the specificity that is needed to achieve clinically applicable treatment regimens. Our goal was to develop a method for gene modification that would yield sustainable production of gene products but would be less time consuming than existing protocols. METHODS: An adenoassociated virus was used to deliver gene products to pectoralis muscle flaps. Gene modification was accomplished via either direct injection or novel fat grafting techniques. RESULTS: The production of gene product was observable by both in vivo imaging and immunohistochemical staining. Gene products were not detected in tissues that were not in contact with the fat grafts that were incubated with the viral vector, indicating that the transduction stayed local to the flap. CONCLUSIONS: Using novel recombinant adenoassociated virus vectors, we have developed a method for gene delivery that is highly efficient and applicable to muscle flaps.
Authors: Joseph Michaels; Michael Dobryansky; Robert D Galiano; Daniel J Ceradini; Robert Bonillas; Deirdre Jones; Natalie Seiser; Jamie P Levine; Geoffrey C Gurtner Journal: Ann Plast Surg Date: 2004-06 Impact factor: 1.539
Authors: Shadi Ghali; Kirit A Bhatt; Marlese P Dempsey; Deidre M Jones; Sunil Singh; Shahram Aarabi; Shahram Arabi; Peter E Butler; Robert L Gallo; Geoffrey C Gurtner Journal: Plast Reconstr Surg Date: 2009-04 Impact factor: 4.730
Authors: Shadi Ghali; Marlese P Dempsey; Deirdre M Jones; Raymond H Grogan; Peter E Butler; Geoffrey C Gurtner Journal: Ann Plast Surg Date: 2008-03 Impact factor: 1.539
Authors: Lei Cao; Xianglan Liu; En-Ju D Lin; Chuansong Wang; Eugene Y Choi; Veronique Riban; Benjamin Lin; Matthew J During Journal: Cell Date: 2010-07-09 Impact factor: 41.582
Authors: Lei Cao; En-Ju D Lin; Michael C Cahill; Chuansong Wang; Xianglan Liu; Matthew J During Journal: Nat Med Date: 2009-03-08 Impact factor: 53.440
Authors: Francesco Noé; Angelisa Frasca; Claudia Balducci; Mirjana Carli; Gunther Sperk; Francesco Ferraguti; Asla Pitkänen; Ross Bland; Helen Fitzsimons; Matthew During; Annamaria Vezzani Journal: Neurotherapeutics Date: 2009-04 Impact factor: 7.620
Authors: F Noe; V Vaghi; C Balducci; H Fitzsimons; R Bland; D Zardoni; G Sperk; M Carli; M J During; A Vezzani Journal: Gene Ther Date: 2010-03-11 Impact factor: 5.250